Autonomous Cleanroom PODs™
G-CON PODs offer a solution that reduces budget and facility constraints by providing readily deployable,...
G-Con Manufacturing Announces a Multi-Million Dollar Investment by Pfizer
G-Con Manufacturing has announced a multi-million dollar investment by Pfizer Venture Investments (PVI).
Under terms of the agreement, Bill Burkoth from Pfizer Venture Investments will assume a position on G-Con’s board of directors.
G-Con and Pfizer will continue to work together in the Portable Continuous Miniature and Modular (PCMM) consortium with GEA Process Engineering to develop next-generation oral solid dosage processing technology that addresses rapidly changing requirements of pharmaceutical development and manufacturing.
G-CON Manufacturing president Maik Jornitz said: "We are very encouraged and motivated by this investment, which will accelerate G-CON’s already rapid growth."
Pfizer Venture Investments executive director Bill Burkoth said: "G-Con Manufacturing’s disruptive POD technology can change the pharmaceutical manufacturing landscape.
"The autonomous cleanroom PODs can be deployed quickly and easily, which allows manufacturers to distribute medicines at the time they are needed and also in smaller volumes."
More About This Company
Benefits Analysis Autonomous PODs vs Biologics Modular Shipping Containers
In a changing competitive drug development and distribution environment for the pharmaceutical industry, facilities must...
Ageing Aseptic and Biological Facilities: Renovation and Repurposing
G-CON is hosting an event on Thursday 17 September 2015 from 8:30 to 2:30 (EDT).The...
G-CON Manufacturing Selected to Build Aseptic Formulation and Filling PODs for the University of Tennessee Health Science Center
G-CON Manufacturing has been selected to build a multi-POD ISO Class 7 formulation and filling...